Evidence map›Paper›PMID 30662908›Full record

ArticleBioMed research international2018

Complex Clonal Diversity of

Taghrid S El-Mahdy, Mohamed H Al-Agamy, Mohamed Emara, Assem Barakat, Richard V Goering

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Methicillin-resistantVeterinary world · 2024
    Review
  4. Article
  5. Clonal Flux and Spread ofMicroorganisms · 2023
    Article
  6. Ecology and Genetic Lineages of NasalPathogens (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Pathogens and global health · 2020
    Article
  11. Nasal Carriage byInterdisciplinary perspectives on infectious diseases · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Taghrid S El-MahdyDepartment of Microbiology and Immunology, Faculty of Pharmacy, Helwan University, Cairo, Egypt.ORCID 0000-0003-2315-6801
Mohamed H Al-AgamyDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0001-9868-0355
Mohamed EmaraDepartment of Microbiology and Immunology, Faculty of Pharmacy, Helwan University, Cairo, Egypt.
Assem BarakatCollege of Science, King Saud University, Saudi Arabia.ORCID 0000-0002-7885-3201
Richard V GoeringDepartment of Medical Microbiology and Immunology, School of Medicine, Creighton University, Omaha, NE, USA.
Ahram Canadian University · EGAl-Azhar University · EGCreighton University · USHelwan University · EGKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, 210 healthy participants including community personnel (70), clinical students (68), and healthcare workers (HCWs) (72) from the eastern region of Saudi Arabia were studied. Sixty-three

Indexed as

AdultAnti-Bacterial AgentsCefoxitinCross InfectionFemaleHealth PersonnelHumansMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMiddle AgedNasal CavitySaudi ArabiaStaphylococcal InfectionsStudentsYoung AdultAnti-Bacterial AgentsCefoxitin

Identifiers

PMID30662908
PMCPMC6312594
OpenAlexW2904317512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.